111 Capital Makes New $342,000 Investment in HealthEquity, Inc. $HQY

Key Points

• 111 Capital has made a new investment in HealthEquity, Inc., acquiring 3,262 shares valued at approximately $342,000.
• HealthEquity has received positive ratings from multiple analysts, with target prices ranging from $110.00 to $134.00 and an average rating of "Moderate Buy."
• Insider activity includes EVP Delano Ladd selling 6,000 shares at an average price of $94.11, which resulted in a decrease of their ownership by 7.02%.

111 Capital acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,262 shares of the company's stock, valued at approximately $342,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HQY. Farther Finance Advisors LLC boosted its stake in shares of HealthEquity by 232.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 246 shares of the company's stock worth $26,000 after buying an additional 172 shares during the last quarter. WPG Advisers LLC purchased a new position in shares of HealthEquity in the 1st quarter worth approximately $28,000. Northwestern Mutual Wealth Management Co. boosted its stake in shares of HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after buying an additional 418 shares during the last quarter. Sellwood Investment Partners LLC purchased a new position in shares of HealthEquity in the 2nd quarter worth approximately $58,000. Finally, Larson Financial Group LLC boosted its stake in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after buying an additional 642 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Jefferies Financial Group boosted their target price on HealthEquity from $130.00 to $134.00 and gave the stock a "buy" rating in a research note on Wednesday, September 3rd. JPMorgan Chase & Co. upped their price objective on HealthEquity from $125.00 to $126.00 and gave the company an "overweight" rating in a research note on Wednesday, September 3rd. Raymond James Financial reiterated a "strong-buy" rating and issued a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Weiss Ratings reiterated a "hold (c+)" rating on shares of HealthEquity in a research note on Saturday, September 27th. Finally, Royal Bank Of Canada upped their price objective on HealthEquity from $109.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $119.77.

Insider Activity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction on Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the sale, the executive vice president owned 79,456 shares in the company, valued at $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Trading Down 0.9%

NASDAQ:HQY opened at $87.78 on Tuesday. The company has a market cap of $7.56 billion, a P/E ratio of 53.20, a P/E/G ratio of 1.27 and a beta of 0.47. The stock's fifty day moving average price is $91.99 and its two-hundred day moving average price is $93.87. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.